- West Africa: Armyworm Infestation - Mar 2017
- Benin: Cholera Outbreak - Sep 2016
- Benin/Nigeria/Togo: Lassa Fever Outbreak - Jan 2016
- West Africa: Ebola Outbreak - Mar 2014
- Benin: Cholera Outbreak - Oct 2013
- Benin: Floods - Sep 2013
- Benin: Wild Fires - Jan 2013
- Benin: Cholera Epidemic - Oct 2012
- Benin: Floods - Oct 2012
- West/Central Africa: Meningitis Outbreak - Jan 2012
Most read reports
- Benin: World Bank Provides $40 Million to Improve Access to Basic Services and Expand Social Safety Nets
- WFP Benin Country Brief, June 2018
- Supporting climate resilient agriculture in Benin
- Un compendium des compétences féminines pour l’égalité des sexes au Bénin
- World Bank Board Approves West Africa Coastal Areas (WACA) Resilience Investment Project
GENEVA - African countries increased investments in the Global Fund as global health partners seek to galvanize all sources of funding to end AIDS, tuberculosis and malaria as epidemics, and to build resilient and sustainable systems for health.
88 Million Bed Nets Distributed for Malaria
Geneva - The Global Fund to Fight AIDS, Tuberculosis and Malaria today announced that 2.3 million people living with HIV have been reached with lifesaving antiretroviral (ARV) treatment through AIDS programs it supports, a 31 per cent increase over results reported a year ago.
Global Fund-supported tuberculosis programs have so far put more than 5.4 million people on effective TB drugs treatment. Tuberculosis is the leading cause of death among HIV-infected people; the World Health Organization estimates that TB accounts for up to a …
This fact sheet outlines the principles and approach in determining the number of people on antiretroviral drugs (ARVs) for HIV/AIDS treatment, with a breakdown of the results by country, and answers to commonly-asked questions.
Question 1: How many people are receiving ARVs from programs supported by Global Fund grants?
As of June 1st 2009, programs supported by the Global Fund have reported 2.3 million people currently on ARVs for treatment of HIV/AIDS.
Question 2: What is the regional breakdown of people currently receiving ARVs?